TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,179
|
1,875
|
1,407 |
| Financial expenses |
17
|
20
|
15 |
| Earnings before taxes |
-2,151
|
-1,828
|
-3,215 |
| EBITDA |
-2,067
|
-1,746
|
-3,147 |
| Total assets |
1,379
|
1,240
|
1,700 |
| Current assets |
1,294
|
1,091
|
1,530 |
| Current liabilities |
375
|
447
|
766 |
| Equity capital |
204
|
287
|
555 |
| - share capital |
65
|
64
|
60 |
| Employees (average) |
4
|
4
|
4 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
14.8%
|
23.1%
|
32.6% |
| Turnover per employee |
545
|
469
|
352 |
| Profit as a percentage of turnover |
-98.7%
|
-97.5%
|
-228.5% |
| Return on assets (ROA) |
-154.7%
|
-145.8%
|
-188.2% |
| Current ratio |
345.1%
|
244.1%
|
199.7% |
| Return on equity (ROE) |
-1054.4%
|
-636.9%
|
-579.3% |
| Change turnover |
270
|
369
|
307 |
| Change turnover % |
14%
|
24%
|
28% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.